Search company, investor...
Schulke company logo


Founded Year



Acq - Fin | Alive

About Schulke

Schulke, a subsidiary of Air Liquide, designs and supplies a wide range of disinfectants and antiseptics for the medical environment to actively contribute to patient safety.

Headquarters Location

Robert-Koch Str. 2

Norderstedt, 22851,


+49(0)40 521 00 0

Missing: Schulke's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Schulke's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Schulke Patents

Schulke has filed 1 patent.

The 3 most popular patent topics include:

  • Amines
  • Antiseptics
  • Cannabinoids
patents chart

Application Date

Grant Date


Related Topics




Amines, Disinfectants, Antiseptics, Chemical processes, Food additives


Application Date


Grant Date



Related Topics

Amines, Disinfectants, Antiseptics, Chemical processes, Food additives



Latest Schulke News

Hospital Surgical Disinfectant Market to be worth US$ 796.6 Mn by 2032 | CAGR of 7.3%

Nov 24, 2022

| CAGR of 7.3% The Hospital Surgical Disinfectant Market revenues were estimated at US$ 395 Mn in 2022 and is anticipated to grow at a CAGR of 7.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 797 Mn. The demand for hydrogen peroxide is projected to garner an absolute dollar opportunity of US$ 69.5 Mn during 2022 – 2032. According to the Healthcare Cost and Utilization Project (HCUP), approximately 9 Mn operations were done in ambulatory care settings in the United States in 2020. In the event of operations, one of the most important needs in healthcare facilities is the use of surgical disinfection solutions. These products are more typically used in hospitals and other medical settings to lower the risk of infection during surgery and other operations because they prevent or limit the development of germs on the skin. As a result, such occurrences are projected to boost the market throughout the forecast period. Request a Sample of this Report @ Surgical and diagnostic procedures may be required, which may require medical consumables Surgical Disinfectant. Hospitalization rates are predicted to rise as the frequency of chronic illnesses such as cardiovascular disease, cancer, diabetes, and other autoimmune disorders rises. The adoption of unhealthy and sedentary lifestyles, as well as antibiotic resistance, are the key factors to the increased prevalence of chronic diseases. According to the National Center for Health Statistics, an estimated 157 million Americans suffer from chronic sickness, with 81 million suffering from several conditions, as of 2018. Because of the rising frequency of chronic diseases, hospital admissions have skyrocketed. Surgical disinfectants are needed in hospitals to keep humans and non-living materials germ-free. Such factors are predicted to drive demand for hospital surgical disinfectants throughout the forecast period. Competitive Landscape Corporations are expanding their corporate footprint in emerging areas through strategic alliances and agreements, as well as focusing on improving distribution networks. This is expected to boost the expansion of the high-level disinfection services market. The key vendors in the global market are 3M, Ecolab, BD, Sage Products LLC, B. Braun Melsungen AG, Johnson & Johnson, Kimberly-Clark Corporation, Cardinal Health, The Clorox Company, and Schulke & Mayr GmbH, among others. Request for Customization @ Some of the recent development in the Hospital Surgical Disinfectant market are: In March 2021, Halsted is reported to have developed the latex glove to protect the hands of his scrub nurse, Caroline Hampton, from the harsh antiseptics in widespread use as disinfectants. In February 2019 Schulke & Mayr struck a distribution deal with DKSH, a key service provider, DKSH will sell and promote a wide variety of Schulke’s disinfection products in China under the terms of this agreement. More Insights Available Future Market Insights, in its new offering, presents an unbiased analysis of the Hospital Consumables market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals essential insights on the basis of product type (Chlorhexidine, Alcohols, Povidone-iodine, Octenidine, Hydrogen Peroxide, Other Product Types) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). Speak to our Research Expert : Market Segments Covered in Hospital Surgical Disinfectant Industry Analysis By Product Type:

Schulke Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Schulke Rank

Schulke Frequently Asked Questions (FAQ)

  • When was Schulke founded?

    Schulke was founded in 1889.

  • Where is Schulke's headquarters?

    Schulke's headquarters is located at Robert-Koch Str. 2, Norderstedt.

  • What is Schulke's latest funding round?

    Schulke's latest funding round is Acq - Fin.

  • Who are the investors of Schulke?

    Investors of Schulke include EQT Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.